E

Exact Sciences Corp
D

EXAS

48.500
USD
-0.28
(-0.57%)
مغلق
حجم التداول
81,727
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
9,148,927,141
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
BAX
BAX
0.440
(1.53%)
29.225 USD
BDX
BDX
1.850
(1.01%)
185.410 USD
BSX
BSX
-0.020
(-0.02%)
106.150 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
ILMN
ILMN
1.730
(1.61%)
109.330 USD
MDT
MDT
0.625
(0.68%)
92.975 USD
M
MYGN
-0.20500
(-4.40%)
4.45000 USD
SYK
SYK
6.58
(1.66%)
403.55 USD
T
TNDM
0.445
(2.88%)
15.890 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Exact Sciences Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.